Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors
about
Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug actionThe human prostanoid DP receptor stimulates mucin secretion in LS174T cellsThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsThe trafficking protein GABARAP binds to and enhances plasma membrane expression and function of the angiotensin II type 1 receptor.A single conserved leucine residue on the first intracellular loop regulates ER export of G protein-coupled receptors.DNA display selection of peptide ligands for a full-length human G protein-coupled receptor on CHO-K1 cells.New insights in insurmountable antagonism.Cardio classics revisited--focus on the role of candesartan.Suppression of adrenal βarrestin1-dependent aldosterone production by ARBs: head-to-head comparison.Quantitative pharmacological analysis of antagonist binding kinetics at CRF1 receptors in vitro and in vivoPhylogenetic Diversity of Sponge-Associated Fungi from the Caribbean and the Pacific of Panama and Their In Vitro Effect on Angiotensin and Endothelin Receptors.Recruitment of a cytoplasmic chaperone relay by the A2A adenosine receptor.Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays.Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism.Translocation of the insulin-regulated aminopeptidase to the cell surface: detection by radioligand binding.Regulation of the cell surface expression and function of angiotensin II type 1 receptor by Rab1-mediated endoplasmic reticulum-to-Golgi transport in cardiac myocytes.Characterization of a fluorescent conjugate of the rabbit angiotensin AT(1) receptor.Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor.Non-competitive pharmacological antagonism at the rabbit B(1) receptor.Translational regulation of angiotensin type 1a receptor expression and signaling by upstream AUGs in the 5' leader sequence.Presence and regulation of insulin-regulated aminopeptidase in mouse macrophages.Binding characteristics of [(3)H]-irbesartan to human recombinant angiotensin type 1 receptors.The past, present and future of hypertension management: a potential role for AT(1)-receptor antagonists.Comparison of the antagonistic effects of different angiotensin II receptor blockers in human coronary arteries.Upregulation of angiotensin II type 2 receptor and limitation of myocardial stunning by angiotensin II type 1 receptor blockers during reperfused myocardial infarction in the rat.Role of AT1 receptors and NAD(P)H oxidase in diabetes-aggravated ischemic brain injury.Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker.1-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-pyrrolidine-2-carboxamide: investigation of structural variations.Conformational constraints in angiotensin IV to probe the role of Tyr², Pro⁵ and Phe⁶.Characterisation of angiotensin II receptors in isolated human subcutaneous resistance arteries.Distinctions between non-peptide angiotensin II AT1-receptor antagonists.
P2860
Q24595639-18F23DDE-3521-4F5D-A794-06CAEDA09EC1Q24674203-B4064160-4C8B-49B6-B3EE-FAA16C57EA26Q30486707-8332513C-F60C-4BC7-B016-963FEB8C496BQ33337073-CC528872-5461-44EF-A4EC-EB2ADA8ADA69Q33780776-CD0A1889-EC6A-4471-8327-11C5D6B9081DQ34131036-A953DD4C-89EC-4F31-A46A-79B4309720F2Q34175396-333BBB30-2940-4BD8-A08C-9774BCD32CB2Q34417462-4D61108B-DF7C-48EE-B783-5165B816D126Q35024828-5508CC11-1E7F-4B78-AE1F-335EC7D9EA4DQ35376083-BA197EE8-C40F-4F53-A528-6A750194CBEBQ35647152-32288007-DCAD-4696-86E2-619F6C0426B4Q37213835-C0FF8613-9932-4AD4-954A-526AF678B99BQ37803251-927AAB1D-B3C4-406C-983C-BE45733B5D8AQ39397383-37771FB3-D5AC-4606-A679-038361F82C04Q39572817-E9B6961F-BA53-4D12-B271-DCAB330CB3DDQ40536187-BEFBB5CE-9C44-4A5B-B410-84E275D11F89Q40651399-F28A9F5D-F0BA-4956-9200-346008A8D502Q41896971-B3546E02-D28E-4629-8FDB-CC341475B49CQ42249590-57E2EA7C-EB9A-49A7-8262-9BDDA758CE36Q42633952-2ACBA3EF-416D-4954-8B13-9E99A8CC4316Q42806618-E43DF0D1-D22A-45B4-914E-ECF12FA738F2Q43968022-4852F055-A805-46C5-9484-A86527F064CAQ44010985-39F05704-DCAA-4C61-B1FE-3613DD7FDC0FQ44230612-5E2499A8-CE07-4D9E-ACF9-37DF39A8B100Q44594372-789E8862-606E-44C8-BA30-88E65E4AECEAQ44899587-B82FF787-A3C0-4E38-ABE4-4DCEBDD3730DQ46082168-1B7E7569-C932-4BA0-8F43-C73BB844FAA7Q51766954-1FE22A0B-DE88-47C2-AB02-086526232735Q51768228-8ADB146B-4DEC-4CF2-A069-E39A36DF4310Q54017979-B46F0E3E-BA91-49B6-A8BE-C1E812C4E398Q54793608-9E5E40F5-4E9F-4872-925D-4C34951D918C
P2860
Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Distinction between surmountab ...... n angiotensin II AT1 receptors
@ast
Distinction between surmountab ...... n angiotensin II AT1 receptors
@en
Distinction between surmountab ...... n angiotensin II AT1 receptors
@nl
type
label
Distinction between surmountab ...... n angiotensin II AT1 receptors
@ast
Distinction between surmountab ...... n angiotensin II AT1 receptors
@en
Distinction between surmountab ...... n angiotensin II AT1 receptors
@nl
prefLabel
Distinction between surmountab ...... n angiotensin II AT1 receptors
@ast
Distinction between surmountab ...... n angiotensin II AT1 receptors
@en
Distinction between surmountab ...... n angiotensin II AT1 receptors
@nl
P2093
P2860
P356
P1476
Distinction between surmountab ...... n angiotensin II AT1 receptors
@en
P2093
F L Fierens
G Vauquelin
J P De Backer
N Fraeyman
P M Vanderheyden
P2860
P304
P356
10.1038/SJ.BJP.0702398
P407
P577
1999-02-01T00:00:00Z